Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Tufts Medical Center Inc patents


Recent patent applications related to Tufts Medical Center Inc. Tufts Medical Center Inc is listed as an Agent/Assignee. Note: Tufts Medical Center Inc may have other listings under different names/spellings. We're not affiliated with Tufts Medical Center Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "T" | Tufts Medical Center Inc-related inventors


Precise estimation of glomerular filtration rate from multiple biomarkers

The present invention relates to the field of nephrology. More specifically, the present invention provides methods and compositions useful for more precisely estimating glomerular filtration rate (gfr). ... Tufts Medical Center Inc

Atrial specific antiarrhythmics for use in treating or preventing atrial fibrillation

The invention relates to methods and compositions for treating or preventing atrial fibrillation.. . ... Tufts Medical Center Inc

Endovascular cerebrospinal fluid shunt

Implantable shunt devices and methods for draining cerebrospinal fluid from a patient's subarachnoid space include a shunt having opposed first and second ends, the second end being constructed to penetrate a wall of a sigmoid, transverse, straight, or sagittal sinus of the patient, a one-way valve, a hollow passageway extending between the second end and the one-way valve such that cerebrospinal fluid can be drained through the second end and out through the valve, and a mechanism coupled to the shunt and configured to anchor the shunt at a desired location proximal to the subarachnoid space.. . ... Tufts Medical Center Inc

Predictive instrument to identify patients for use of pharmacological cardiac metabolic support

A purpose-made predictive instrument for the administration of cardiac metabolic support for acute coronary syndromes (acs, which include unstable angina and acute myocardial infarction) that particularly identifies those most likely to benefit from treatment. In some examples, such a predictive instrument is used for real-time decision support for the administration of treatments such as glucoseinsulin-potassium (gik).. ... Tufts Medical Center Inc

Par-1 activation by metalloproteinase-1 (mmp-1)

Matrix metalloproteases (mmps) play many important roles in normal and pathological remodeling processes including atherothrombotic disease, inflammation, angiogenesis and cancer. This invention relates to the activation of protease-activated receptor-1 (par-1) by endogenous platelet mmp-1 collagenase on the surface of platelets. ... Tufts Medical Center Inc

Systems and methods for treating acute and chronic heart failure

Systems and methods and devices are provided for arresting or reversing the effects of myocardial remodeling and degeneration after cardiac injury, without the potential drawbacks associated with previously existing systems and methods, by at least partially occluding flow through the superior vena cava over multiple cardiac cycles, and more preferably, by adjusting the interval or degree of occlusion responsive to a sensed level of patient activity. In some embodiments, a controller is provided that actuates a drive mechanism responsive to a sensed level of patient activity to provide at least partial occlusion of the patient's superior vena cava, while a data transfer circuit of the controller provides bi-directional transfer of physiologic data to the patient's smartphone or tablet to permit display and review of such data.. ... Tufts Medical Center Inc

Endovascular cerebrospinal fluid shunt

An endovascular implantable shunt device for draining cerebrospinal fluid from a patient's subarachnoid space includes a shunt having opposed first and second ends, a one-way valve located at the first end of the shunt, a tip disposed at the second end, and a hollow passageway extending between the tip and one-way valve. The tip is constructed to penetrate a patient's sinus wall. ... Tufts Medical Center Inc

Anti-cd38 antibodies for treatment of light chain amyloidosis and other cd28-positive hematological malignancies

The present invention relates to methods of treatment of light chain amyloidosis and other cd38-positive hematological malignancies with anti-cd38 antibodies.. . ... Tufts Medical Center Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Tufts Medical Center Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Tufts Medical Center Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###